Vident Investment Advisory’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,247
| Closed | -$34.1K | – | 1300 |
|
|
2023
Q1 | $34.1K | Buy |
3,247
+56
| +2% | +$588 | ﹤0.01% | 1217 |
|
|
2022
Q4 | $108K | Sell |
3,191
-11,097
| -78% | -$376K | ﹤0.01% | 1098 |
|
|
2022
Q3 | $679K | Sell |
14,288
-1,073
| -7% | -$51K | 0.02% | 694 |
|
|
2022
Q2 | $875K | Buy |
15,361
+8,918
| +138% | +$508K | 0.03% | 665 |
|
|
2022
Q1 | $521K | Buy |
6,443
+833
| +15% | +$67.4K | 0.01% | 917 |
|
|
2021
Q4 | $1.14M | Sell |
5,610
-42
| -0.7% | -$8.51K | 0.03% | 653 |
|
|
2021
Q3 | $1.52M | Sell |
5,652
-1,028
| -15% | -$277K | 0.05% | 546 |
|
|
2021
Q2 | $1.72M | Sell |
6,680
-34
| -0.5% | -$8.75K | 0.05% | 470 |
|
|
2021
Q1 | $2.02M | Buy |
6,714
+42
| +0.6% | +$12.6K | 0.07% | 372 |
|
|
2020
Q4 | $1.7M | Buy |
6,672
+2,455
| +58% | +$626K | 0.07% | 348 |
|
|
2020
Q3 | $1.05M | Sell |
4,217
-599
| -12% | -$149K | 0.05% | 474 |
|
|
2020
Q2 | $1.67M | Buy |
4,816
+108
| +2% | +$37.5K | 0.09% | 256 |
|
|
2020
Q1 | $1.26M | Sell |
4,708
-3,616
| -43% | -$968K | 0.08% | 310 |
|
|
2019
Q4 | $2.7M | Buy |
8,324
+5,556
| +201% | +$1.8M | 0.17% | 148 |
|
|
2019
Q3 | $756K | Sell |
2,768
-1,017
| -27% | -$278K | 0.07% | 224 |
|
|
2019
Q2 | $2.02M | Sell |
3,785
-3,585
| -49% | -$1.91M | 0.16% | 87 |
|
|
2019
Q1 | $3.71M | Buy |
7,370
+3,649
| +98% | +$1.84M | 0.2% | 88 |
|
|
2018
Q4 | $1.83M | Sell |
3,721
-28
| -0.7% | -$13.8K | 0.1% | 274 |
|
|
2018
Q3 | $3.43M | Buy |
3,749
+216
| +6% | +$198K | 0.13% | 183 |
|
|
2018
Q2 | $2.59M | Buy |
3,533
+1,176
| +50% | +$861K | 0.1% | 273 |
|
|
2018
Q1 | $3.19M | Buy |
2,357
+934
| +66% | +$1.26M | 0.13% | 212 |
|
|
2017
Q4 | $1.56M | Buy |
+1,423
| New | +$1.56M | 0.07% | 309 |
|